Routine health outcomes measurement

Four-Year Colleges and Universities Report Over Half of Undergraduate Students Completed Degrees Within 8 Years

Retrieved on: 
Tuesday, December 12, 2023

WASHINGTON, Dec. 12, 2023 /PRNewswire/ -- More than half of undergraduate students who entered a four-year, degree-granting U.S. postsecondary institution in 2014-15 – 54 percent –completed their degree or certificate at the institution where they started within 8 years, according to provisional data from the National Center for Education Statistics (NCES), the statistical center within the U.S. Department of Education's Institute of Education Sciences (IES). The comparable figure for completion for undergraduate students who entered four-year degree granting postsecondary institutions the prior year (2013-14) was 52 percent.

Key Points: 
  • The comparable figure for completion for undergraduate students who entered four-year degree granting postsecondary institutions the prior year (2013-14) was 52 percent.
  • At two-year degree granting postsecondary institutions in the U.S., 31 percent of undergraduate students completed a degree or certificate within 8 years of entering in 2014-15.
  • For those who entered two-year institutions one year earlier (2013-14), 30 percent completed a degree or certificate within 8 years.
  • They reflect outcomes for the cohort of degree- or certificate-seeking undergraduate students who began postsecondary education in 2014-15.

KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs

Retrieved on: 
Wednesday, October 12, 2022

KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development of innovative and easy-to-use subcutaneous (SQ) infusion solutions, today announced the appointment of Brent Rutland as the Companys new Vice President of Medical Affairs.

Key Points: 
  • KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development of innovative and easy-to-use subcutaneous (SQ) infusion solutions, today announced the appointment of Brent Rutland as the Companys new Vice President of Medical Affairs.
  • Most notably, Brent aided Baxter in the launch of Hylenex for SQ rehydration where he also helped build the Medical Affairs department.
  • I was immediately drawn to the opportunity to work at KORU Medical as I saw the potential for future growth supported by building out the medical science and the team, said Brent Rutland, Vice President of Medical Affairs.
  • Medical affairs helps fulfill the unmet needs of the patient through the generation and delivery of scientific evidence to various key outside stakeholders.

LifePoint Health Partners with Health Catalyst to Advance Patient Care

Retrieved on: 
Wednesday, July 27, 2022

SALT LAKE CITY, July 27, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year partnership with LifePoint Health, a diversified healthcare delivery network that operates 63 community hospital campuses, more than 30 rehabilitation and behavioral health hospitals, and 170 additional sites of care from coast to coast.

Key Points: 
  • "Partnering with Health Catalyst will enable us to better leverage important clinical data that can drive meaningful improvements in patient care, safety and satisfaction while advancing our mission of Making Communities Healthier," said Christopher Rehm, MD, senior vice president and chief medical officer of LifePoint Health.
  • LifePoint Health has selected the Health Catalyst Data Operating System (DOS) platform, Pop Analyzer , Pop Insights , Healthcare.AI , Patient Safety Monitor , MeasureAble , Instant Data Entry Application (IDEA), and Analytics Accelerators.
  • "We have great admiration for LifePoint Health and are honored to have the opportunity to support the organization's efforts to improve quality and safety as a leader in community-based care," said Dan Burton, CEO of Health Catalyst.
  • "The Health Catalyst DOS platform, along with our technology product suites and applications, and improvement expertise, will best position LifePoint Health to achieve, sustain, and scale the highest standards of care across its network."

Health Catalyst and Akron Children's Hospital Team Up to Advance Population Health Efforts

Retrieved on: 
Tuesday, July 26, 2022

"Health Catalyst will become a fundamental component of our robust analytics platform, which will bring multiple sources of data to assist in data-driven decision making," said Harun Rashid, Chief Information Officer for Akron Children's.

Key Points: 
  • "Health Catalyst will become a fundamental component of our robust analytics platform, which will bring multiple sources of data to assist in data-driven decision making," said Harun Rashid, Chief Information Officer for Akron Children's.
  • Together, Health Catalyst and Akron Children's will implement Health Catalyst's enterprise analytics and population health outcomes improvement expertise to transform clinical, operational, and financial domainsfor Akron Children's and the hospital's accountable care organization Akron Children's Health Collaborative (ACHC).
  • Akron Children's comprehensive population health solution will include Health Catalyst's Data Operating System (DOS) platform , Pop Analyzer: Stratify Expert Data Collection , Value Optimizer, MeasureAble, Health Catalyst Embedded Care Gaps, and a team of population health and analytics experts.
  • Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement.

Feinstein Institutes Begins Pilot Trial to Reduce Cardiovascular Disease in the Black Community

Retrieved on: 
Thursday, December 16, 2021

The Feinstein Institutes for Medical Research , the science arm of Northwell Health , recently received a $150,000 grant from TD Bank, America's Most Convenient Bank, to launch a new research program and the first clinical trial to reduce cardiovascular disease (CVD) in the Black community and determine the best behavioral interventions to lower cardiovascular disease.

Key Points: 
  • The Feinstein Institutes for Medical Research , the science arm of Northwell Health , recently received a $150,000 grant from TD Bank, America's Most Convenient Bank, to launch a new research program and the first clinical trial to reduce cardiovascular disease (CVD) in the Black community and determine the best behavioral interventions to lower cardiovascular disease.
  • View the full release here: https://www.businesswire.com/news/home/20211216005126/en/
    Mark Butler, PhD, is the principal investigator on the new trial using smart prescription bottles.
  • CVD disproportionally affects the Black community, but this disparity could be addressed by increasing adherence to protocols for taking potentially life-saving medications.
  • Cardiovascular disease is a major driver of death, particularly among people in the Black community.